The p53 tumor suppressor gene in breast cancer

Richard M Elledge, D. Craig Allred

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Alterations of the p53 tumor suppressor gene are the most common genetic changes found so far in breast cancer, suggesting that the gene plays a central role in the development of the disease. p53 functions as a negative regulator of cell growth, and alterations in the gene lead to loss of this negative growth regulation and more rapid cell proliferation. A number of independent groups using different methods of detection have shown that p53 alterations are associated with more aggressive tumor biologic factors and a poorer prognosis in breast cancer patients. Because of its possible role in the regulation of apoptosis and response to DNA damage, p53 status could also be a predictive marker for response to hormonal or chemotherapy.

Original languageEnglish (US)
Pages (from-to)39-47
Number of pages9
JournalBreast Cancer Research and Treatment
Volume32
Issue number1
DOIs
StatePublished - Jan 1994

Fingerprint

Tumor Suppressor Genes
Breast Neoplasms
Neoplasm Genes
Biological Factors
Growth
DNA Damage
Cell Proliferation
Apoptosis
Drug Therapy
Genes
Neoplasms

Keywords

  • breast cancer
  • p53 gene
  • p53 protein
  • prognosis
  • therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The p53 tumor suppressor gene in breast cancer. / Elledge, Richard M; Allred, D. Craig.

In: Breast Cancer Research and Treatment, Vol. 32, No. 1, 01.1994, p. 39-47.

Research output: Contribution to journalArticle

Elledge, Richard M ; Allred, D. Craig. / The p53 tumor suppressor gene in breast cancer. In: Breast Cancer Research and Treatment. 1994 ; Vol. 32, No. 1. pp. 39-47.
@article{83bf106558cc4680a6fea768c57bb0fb,
title = "The p53 tumor suppressor gene in breast cancer",
abstract = "Alterations of the p53 tumor suppressor gene are the most common genetic changes found so far in breast cancer, suggesting that the gene plays a central role in the development of the disease. p53 functions as a negative regulator of cell growth, and alterations in the gene lead to loss of this negative growth regulation and more rapid cell proliferation. A number of independent groups using different methods of detection have shown that p53 alterations are associated with more aggressive tumor biologic factors and a poorer prognosis in breast cancer patients. Because of its possible role in the regulation of apoptosis and response to DNA damage, p53 status could also be a predictive marker for response to hormonal or chemotherapy.",
keywords = "breast cancer, p53 gene, p53 protein, prognosis, therapy",
author = "Elledge, {Richard M} and Allred, {D. Craig}",
year = "1994",
month = "1",
doi = "10.1007/BF00666204",
language = "English (US)",
volume = "32",
pages = "39--47",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - The p53 tumor suppressor gene in breast cancer

AU - Elledge, Richard M

AU - Allred, D. Craig

PY - 1994/1

Y1 - 1994/1

N2 - Alterations of the p53 tumor suppressor gene are the most common genetic changes found so far in breast cancer, suggesting that the gene plays a central role in the development of the disease. p53 functions as a negative regulator of cell growth, and alterations in the gene lead to loss of this negative growth regulation and more rapid cell proliferation. A number of independent groups using different methods of detection have shown that p53 alterations are associated with more aggressive tumor biologic factors and a poorer prognosis in breast cancer patients. Because of its possible role in the regulation of apoptosis and response to DNA damage, p53 status could also be a predictive marker for response to hormonal or chemotherapy.

AB - Alterations of the p53 tumor suppressor gene are the most common genetic changes found so far in breast cancer, suggesting that the gene plays a central role in the development of the disease. p53 functions as a negative regulator of cell growth, and alterations in the gene lead to loss of this negative growth regulation and more rapid cell proliferation. A number of independent groups using different methods of detection have shown that p53 alterations are associated with more aggressive tumor biologic factors and a poorer prognosis in breast cancer patients. Because of its possible role in the regulation of apoptosis and response to DNA damage, p53 status could also be a predictive marker for response to hormonal or chemotherapy.

KW - breast cancer

KW - p53 gene

KW - p53 protein

KW - prognosis

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=0027992938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027992938&partnerID=8YFLogxK

U2 - 10.1007/BF00666204

DO - 10.1007/BF00666204

M3 - Article

C2 - 7819584

AN - SCOPUS:0027992938

VL - 32

SP - 39

EP - 47

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -